We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Intl.Medical | LSE:INT | London | Ordinary Share | GB00B035PZ17 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.83 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/8/2006 05:17 | Hi Ged5 There is nothing wrong with this company it is just market sentiment and if you are a long term holder it does not matter. Jo had not done his homework by the sounds of things and just wanted to stir it. I still wonder why they brough those 5 million needles and I can only think that there is another deal in the pipeline possibly South Africa or even Europe but I dont know, just cant see them buying without something being in place. Very busy at work next week buy I will ring them after the bank holiday and see if I can find out why they brought them along if any other info I can get. Have a great weekend all | martincoops | |
18/8/2006 21:34 | You could start to think INT looks good from here!maybe not but looks set to bounce. | j4ckthehat | |
18/8/2006 21:10 | "International Medical Devices (IMD or 'the Company') is delighted to announce that initial production runs of its ClipOnTM 'safe' needle device have begun for delivery into the NHS and also South Africa. Production is taking place at the Eastland Medical Systems plant in Portland, Australia, following IMD's acquisition of the patents over a range of safe devices from Eastland Technology Australia (ETA). The NHS Purchasing and Supply Agency currently buys 136 million needles per year, of which 50 per cent are 21 gauge needles. The total UK market is estimated at approximately 200 million per year. IMD will initially target this 21 gauge market, i.e. 70 million needles. IMD, with its associate company EMS, also intends to address the growing need for safe needles in sub-Saharan Africa where HIV is causing such devastation. To this end it is working with the Nelson Mandela Foundation. The World Health Organisation estimates that at least five per cent of HIV has been contracted through the use of unsterile needles. IMD's safe needles can be used once only and once retracted are fully secure. Trials begin in five NHS Trust hospitals of IMD's ClipOnTM safe needle device later this month and the needle buyer for the NHS Purchasing and Supply Agency (PASA) has agreed to support the fast-track launch of the Company's products into the Service for launch in April. The Company's assessment of the UK, European, South African and Australian markets indicates initial potential demand for the ClipOnTM safe retractable needle is in the order of 300 million units annually. Volumes in excess of 100 million units are anticipated to substantially reduce production costs and open up further markets. Last month IMD reported that it has enjoyed an outstanding six months following the acquisition of the medical distributor Meddis Ltd in September 2005, with Meddis sales for last November up by 29 per cent over the same month in 2004 and January sales up 46 per cent on 2005. Chris Thomas, Chief Executive of IMD said: 'We are now entering a period of great activity and growth exactly in line with our stated strategy. We believe we can make a very real and valuable contribution to the safety of healthcare staff in the NHS with the introduction of our cost effective, safe needles. The overall savings to the Service by eliminating days lost through needlestick injuries - up to 100,000 each year - should be in the region of £10 million annually'." This is what brought me into this company after checking the previous results and the trading statement in February. It looked like an opportunity to invest in a company with tremendous potential. However since then we have had delays in the NHS launch and have to make modifications to the the needles. Doesn't sound too good. Now we have to wait until Q4 for the NHS assessments. And all this after buying 5m ClipOn needles. Look at the chart and you soon see this was a bloody awful investment. So why do we need a Guardian Angel? Yes you jotoha1. Why do you have to come along and warn us of this poor, poor investment? ;) I've never had anyone come along to help me before. So why now? What do you know? Why do you have other people's interest at heart? You've mentioned Thomas. Do you have a gripe with him? You've mentioned 8M intangibles. Have you looked at the patents? Are these not intangibles? Why have you started posting here? Don't you think these acquisitions have been good? Don't you think there is potential here? Don't you think there are some good people managing this company? | ged5 | |
18/8/2006 18:32 | Martin, lets just wait for the full year results | jotoha1 | |
18/8/2006 09:00 | Martin, ask any savvy accountant and he will tell you net assets are the true indicator of value, it's like saying my house is worth 100 times what the next 10 years fo inflation will do to it, it's worth what the maket dictates, ie what is it worth as an asset. If EMS are making £1.5m profit per year then the share price would not be where it is now...the market has taken a view of where we are now and thats down...look at the graph, just watch and learn as we now enter a period of excuses for poor trading!!!!!!!!!!! | jotoha1 | |
17/8/2006 21:13 | Jo Just a couple of points to note. The shares were issued at 7p, now whatever spin you try and put on it the fact remains that it was 7p. The owners are not 'out' in fact they are in, they have not left the company and now have the incentive to achieve the earn outs and if they dont they miss out on large amounts of dosh. Sounds like good business sense to me. Would you sell a company for £200,000 when you are making £125,000 a year before tax, not bloody likely, no you would want alot more and that is what they will get if they achieve the earn outs. INT are a profitable company now making in the region £1.5 million before tax with further rapid growth expected along with further acqusitions. | martincoops | |
17/8/2006 19:04 | Post removed by ADVFN | Abuse team | |
17/8/2006 18:41 | Martin, they did not issue them to the market for 7p, but to the poor old owners , who appear to have been stitched up,(not really though) they must have been desperate to get out, and why would that be , may I ask, time will confirm the worst for sure! Did you also notice that the vendors agreed to future payments based on projected net profits of £800,000 over 3 years...pie in the sky, vendors were happy to pick up £200 000 and sail awail into the sunset..now thats doing a good deal!! Fancy paying £200,000 for net assets worth less than £10,000 , are we playing Simpsons monopoly or what here? | jotoha1 | |
17/8/2006 07:17 | Agreed Martin, there's a big difference between raising money for general expenses and raising money for shrewd company purchases. Some people just don't get the difference. Having said that, if our CEO has a more chequered history than I realised, it's worth looking at. | james t kirk | |
16/8/2006 19:19 | Why feel sorry jo Infact I am quite happy with my holding. Most companies issue shares when purchasing a comapany but hardly any issue those shares at a high price than the current share price. Please feel free to drop back in next year and see how we are doing. | martincoops | |
16/8/2006 10:59 | And what the hell is that £8 million of intangibles in the accounts, creative accounting or what? | jotoha1 | |
16/8/2006 10:35 | Feel sorry for you guys, just look what Thomas and co have DONE for shareholders in FAR, they will continue to issue paper for as long as they can get away with it, it appears that he is trying the same trick here, the only saving grace here is that more savy shareholders are not falling for it second time around, hence the share decline, just imagine when they issue another 300million shares!!!! great way to make a living! | jotoha1 | |
12/8/2006 02:36 | Yep quite agree with you James however I am happy to pick more up at 4.62p if I can. Lets hope any trading statement has a bit of meat on it to take us back to 8p where we belong. Would also love to see this overhang clear as well as you can still buy at 5p at the moment | martincoops | |
11/8/2006 06:38 | Hi Martin, still here just been away. Surprised the 7p placing didn't have a positive impact on share price as the new company in theory are taking a big loss unless they feel confident that the 7p will be exceeded in the short term? | james t kirk | |
04/8/2006 02:35 | Just incase there is anybody else holding these this is what they have brought | martincoops | |
02/8/2006 07:14 | Well some good and some bad news, trials of the needle on going and we wont hear until end of year now. The good news is that the new shares have been placed at 7p Could be a funny old day today. | martincoops | |
01/8/2006 20:37 | A lame Change Of Advisor was not really the news I was waiting for! | pgrifster | |
01/8/2006 16:35 | Well no news found and I see the share price continues in its downward direction :(( But look on the bright side I took another 10,000 @4.62 this is well under valued now with at least £1.5m profit before tax we should be around the 8p mark Still happy to hold but woud like to see some sign of the needle contract or progress of one. Lots of other bits of news due as well. Good luck all | martincoops | |
19/7/2006 19:08 | Well its been a very exciting 16 days since I last posted, yawn! Will have a root around and see if I can find any other news | martincoops | |
03/7/2006 09:57 | Thanks James I have a feeling that the next 6 months are going to be very exciting with plenty of news :-)) | martincoops | |
03/7/2006 06:58 | Hi Martin all done. Wonder when IMS will tell us why they bought the 5m needles off Eastland, not that we don't know, but would help the share price! | james t kirk | |
02/7/2006 03:54 | James just to make it easier for others could you put the asx link in the header for EasTland Medical. I have posted it below for you. Cheers | martincoops | |
02/7/2006 03:43 | Still working hard on my research. Having listened to the broadcast it sounds as if they should have the new South African plant up and running in 6 months. I loved the bit about Acquisitions that they are party to, sounds as if INT may be making an announcment on this soon as they did mention to me when I spoke to them a month or so ago that they were on the acquisition trail. Here is the link for those that have not listened to it yet | martincoops | |
02/7/2006 01:30 | Morning all Just been rereading some of the old RNS's from INT and came across this snip The NHS Purchasing and Supply Agency currently buys 136 million needles per year, of which 50 per cent are 21 gauge needles. The total UK market is estimated at approximately 200 million per year. IMD will initially target this 21 gauge market, i.e. 70 million needles. IMD, with its associate company EMS, also intends to address the growing need for safe needles in sub-Saharan Africa where HIV is causing such devastation. To this end it is working with the Nelson Mandela Foundation. The World Health Organisation estimates that at least five per cent of HIV has been contracted through the use of unsterile needles. IMD's safe needles can be used once only and once retracted are fully secure. 70 million needles plus per year for the NHS wow, but what really caught my eye was the bit about Africa this confirms my believe that we are involved in this area. In the last RNS from Eastland they state they are going to increase the production at the new planned South African plant from 50 to 100 million units a year but the best bit is that they expect the unit to be fully committed by the time it is fully operational. Now all I need to do is find the date they expect to be up and running. | martincoops |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions